Adaptimmune Aims To Quickly Convert Teclera’s Accelerated Approval

 
• By Bridget Silverman
  
building under construction
Adaptimmune plans to fill out its Teclera label with confirmatory evidence to be submitted 2025. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews